SAI
UTHR icon

Savvy Advisors Inc’s United Therapeutics UTHR Stock Holding History

Savvy Advisors Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Sell
473
-108
-19% -$60.8K 0.01% 1067
2026
Q1 		$345K Sell
581
-45
-7% -$22.4K 0.01% 806
2025
Q4 		$305K Buy
+626
New +$292K 0.01% 763

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Savvy Advisors Inc's UTHR Position: Q2 2026 in Review

Savvy Advisors Inc reduced its United Therapeutics (UTHR) stake by 19% in Q2 2026, selling an estimated $60.8K and leaving 473 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #1067.

Savvy Advisors Inc first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $345K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Savvy Advisors Inc held 473 shares of United Therapeutics worth $256K as of Q2 2026.
  • Savvy Advisors Inc sold 108 United Therapeutics shares in Q2 2026, an estimated $60.8K.
  • United Therapeutics made up 0.01% of Savvy Advisors Inc's portfolio in Q2 2026, its #1067 holding.
  • Savvy Advisors Inc first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Savvy Advisors Inc's United Therapeutics position peaked at $345K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.